[Form 4] L3Harris Technologies, Inc. Insider Trading Activity
Christopher E. Kubasik, Chair and CEO and a director of L3Harris Technologies (LHX), reported transactions dated 08/11/2025 involving company common stock. The filing shows a sale of 40,138 shares with weighted average sale prices reported in a range of $267.99 to $270.63. The report also discloses a non-qualified stock option position with an exercise price of $149.31 covering 40,138 shares (exercisable 06/29/2019, expiring 12/20/2027). The filing notes 30,000 shares held indirectly by a grantor retained annuity trust. All transactions were reported on a Form 4 signed by an attorney-in-fact.
Christopher E. Kubasik, Presidente e CEO nonch茅 amministratore di L3Harris Technologies (LHX), ha segnalato operazioni datate 08/11/2025 relative ad azioni ordinarie della societ脿. La comunicazione indica la vendita di 40,138 azioni con prezzi medi ponderati di vendita riportati nel range di $267.99 a $270.63. Il rapporto rivela inoltre una posizione in opzioni su azioni non qualificate con prezzo di esercizio di $149.31 che riguarda 40,138 azioni (esercitabile dal 06/29/2019, con scadenza 12/20/2027). La documentazione segnala 30,000 azioni detenute indirettamente tramite un grantor retained annuity trust (GRAT). Tutte le operazioni sono state riportate su un Form 4 sottoscritto da un procuratore.
Christopher E. Kubasik, presidente y CEO y director de L3Harris Technologies (LHX), inform贸 transacciones con fecha 08/11/2025 relacionadas con acciones ordinarias de la compa帽铆a. El informe muestra la venta de 40,138 acciones con precios medios ponderados de venta en un rango de $267.99 a $270.63. Tambi茅n divulga una posici贸n de opciones sobre acciones no calificadas con precio de ejercicio de $149.31 que cubre 40,138 acciones (ejercitable desde 06/29/2019, con vencimiento el 12/20/2027). La presentaci贸n indica que 30,000 acciones se mantienen de forma indirecta mediante un grantor retained annuity trust (GRAT). Todas las transacciones fueron reportadas en un Form 4 firmado por un apoderado.
Christopher E. Kubasik電� L3Harris Technologies(LHX)鞚� 鞚橃灔 瓴� CEO鞚挫瀽 鞚挫偓搿滌劀 08/11/2025鞛� 須岇偓 氤错喌欤� 甏�霠� 瓯半灅毳� 鞁犼碃頄堨姷雼堧嫟. 鞁犼碃靹涤棎电� 40,138欤�鞚� 毵る弰鞕� 毵る弰 臧�欷� 韽夑窢臧�臧� $267.99 攵�韯� $270.63 氩旍渼鞐� 頃措嫻頃滊嫟瓿� 旮办灛霅橃柎 鞛堨姷雼堧嫟. 氤搓碃靹滌棎電� 霕愴暅 頄夓偓臧�臧� $149.31鞚� 牍勳瀽瓴� 欤检嫕毵れ垬靹犿儩甓岇澊 40,138欤�鞐� 雽�頃� 臁挫灛頃�(頄夓偓臧�電レ澕 06/29/2019, 毵岆鞚� 12/20/2027)霃� 瓿店皽霅橃柎 鞛堨姷雼堧嫟. 氍胳劀鞐愲姅 30,000欤�臧� grantor retained annuity trust(GRAT)毳� 韱淀暣 臧勳爲 氤挫湢霅橁碃 鞛堨潓鞚� 氇呾嫓霅橃柎 鞛堨姷雼堧嫟. 氇摖 瓯半灅電� 雽�毽澑鞚� 靹滊獏頃� Form 4鞐� 氤搓碃霅橃棃鞀惦媹雼�.
Christopher E. Kubasik, pr茅sident du conseil et PDG ainsi qu'administrateur de L3Harris Technologies (LHX), a d茅clar茅 des op茅rations dat茅es du 08/11/2025 concernant des actions ordinaires de la soci茅t茅. Le dossier indique la vente de 40,138 actions avec des prix de vente moyens pond茅r茅s rapport茅s dans une fourchette de $267.99 脿 $270.63. Le rapport divulgue 茅galement une option d'achat d'actions non qualifi茅e avec un prix d'exercice de $149.31 portant sur 40,138 actions (exer莽able depuis le 06/29/2019, expirant le 12/20/2027). Le d茅p么t signale 30,000 actions d茅tenues indirectement par un grantor retained annuity trust (GRAT). Toutes les op茅rations ont 茅t茅 d茅clar茅es sur un Form 4 sign茅 par un mandataire.
Christopher E. Kubasik, Vorsitzender und CEO sowie Direktor von L3Harris Technologies (LHX), meldete Transaktionen vom 08/11/2025 in Bezug auf Stammaktien des Unternehmens. Die Einreichung weist einen Verkauf von 40,138 Aktien mit gewichteten durchschnittlichen Verkaufspreisen im Bereich von $267.99 bis $270.63 aus. Der Bericht offenbart au脽erdem eine nicht qualifizierte Aktienoption mit einem Aus眉bungspreis von $149.31, die 40,138 Aktien abdeckt (aus眉bbar ab 06/29/2019, Laufzeit bis 12/20/2027). Die Einreichung vermerkt 30,000 Aktien, die indirekt von einem Grantor Retained Annuity Trust (GRAT) gehalten werden. Alle Transaktionen wurden in einem Form 4 gemeldet, das von einem Bevollm盲chtigten unterzeichnet wurde.
- Timely insider disclosure by the Chair and CEO on Form 4, fulfilling Section 16 reporting requirements
- Option details disclosed: non-qualified option exercise price of $149.31 covering 40,138 shares with exercisable and expiration dates
- Reported disposition of 40,138 shares on 08/11/2025 with weighted average sale prices ranging $267.99鈥�$270.63
- Form provides no explanatory detail within the filing about the reason for the sale or any associated trading plan
Insights
TL;DR: CEO reported exercise of options and a contemporaneous sale of 40,138 shares at roughly $268鈥�$271 per share.
The filing documents an option-related position with an exercise price of $149.31 for 40,138 shares alongside a reported disposition of the same number of shares on 08/11/2025. The disclosed sale prices ranged from $267.99 to $270.63, suggesting the transactions involved material cash proceeds relative to a single-day insider sale. The presence of exercised options and an associated sale is consistent with common executive liquidity events and option-exercise activity, but the filing contains no commentary on the purpose of the sale or any 10b5-1 plan designation.
TL;DR: Insider disclosure is complete and timely; transactions include option-related activity and indirect holdings in a trust.
The Form 4 identifies Christopher Kubasik as both an officer (Chair and CEO) and director, and reports indirect ownership of 30,000 shares in a grantor retained annuity trust. The filing appears to disclose the material elements required under Section 16, including exercise price, exercisable and expiration dates for the non-qualified option. The form does not provide any additional governance context such as whether the sale was pre-planned or required by diversification needs, so governance implications must be judged on this factual disclosure alone.
Christopher E. Kubasik, Presidente e CEO nonch茅 amministratore di L3Harris Technologies (LHX), ha segnalato operazioni datate 08/11/2025 relative ad azioni ordinarie della societ脿. La comunicazione indica la vendita di 40,138 azioni con prezzi medi ponderati di vendita riportati nel range di $267.99 a $270.63. Il rapporto rivela inoltre una posizione in opzioni su azioni non qualificate con prezzo di esercizio di $149.31 che riguarda 40,138 azioni (esercitabile dal 06/29/2019, con scadenza 12/20/2027). La documentazione segnala 30,000 azioni detenute indirettamente tramite un grantor retained annuity trust (GRAT). Tutte le operazioni sono state riportate su un Form 4 sottoscritto da un procuratore.
Christopher E. Kubasik, presidente y CEO y director de L3Harris Technologies (LHX), inform贸 transacciones con fecha 08/11/2025 relacionadas con acciones ordinarias de la compa帽铆a. El informe muestra la venta de 40,138 acciones con precios medios ponderados de venta en un rango de $267.99 a $270.63. Tambi茅n divulga una posici贸n de opciones sobre acciones no calificadas con precio de ejercicio de $149.31 que cubre 40,138 acciones (ejercitable desde 06/29/2019, con vencimiento el 12/20/2027). La presentaci贸n indica que 30,000 acciones se mantienen de forma indirecta mediante un grantor retained annuity trust (GRAT). Todas las transacciones fueron reportadas en un Form 4 firmado por un apoderado.
Christopher E. Kubasik電� L3Harris Technologies(LHX)鞚� 鞚橃灔 瓴� CEO鞚挫瀽 鞚挫偓搿滌劀 08/11/2025鞛� 須岇偓 氤错喌欤� 甏�霠� 瓯半灅毳� 鞁犼碃頄堨姷雼堧嫟. 鞁犼碃靹涤棎电� 40,138欤�鞚� 毵る弰鞕� 毵る弰 臧�欷� 韽夑窢臧�臧� $267.99 攵�韯� $270.63 氩旍渼鞐� 頃措嫻頃滊嫟瓿� 旮办灛霅橃柎 鞛堨姷雼堧嫟. 氤搓碃靹滌棎電� 霕愴暅 頄夓偓臧�臧� $149.31鞚� 牍勳瀽瓴� 欤检嫕毵れ垬靹犿儩甓岇澊 40,138欤�鞐� 雽�頃� 臁挫灛頃�(頄夓偓臧�電レ澕 06/29/2019, 毵岆鞚� 12/20/2027)霃� 瓿店皽霅橃柎 鞛堨姷雼堧嫟. 氍胳劀鞐愲姅 30,000欤�臧� grantor retained annuity trust(GRAT)毳� 韱淀暣 臧勳爲 氤挫湢霅橁碃 鞛堨潓鞚� 氇呾嫓霅橃柎 鞛堨姷雼堧嫟. 氇摖 瓯半灅電� 雽�毽澑鞚� 靹滊獏頃� Form 4鞐� 氤搓碃霅橃棃鞀惦媹雼�.
Christopher E. Kubasik, pr茅sident du conseil et PDG ainsi qu'administrateur de L3Harris Technologies (LHX), a d茅clar茅 des op茅rations dat茅es du 08/11/2025 concernant des actions ordinaires de la soci茅t茅. Le dossier indique la vente de 40,138 actions avec des prix de vente moyens pond茅r茅s rapport茅s dans une fourchette de $267.99 脿 $270.63. Le rapport divulgue 茅galement une option d'achat d'actions non qualifi茅e avec un prix d'exercice de $149.31 portant sur 40,138 actions (exer莽able depuis le 06/29/2019, expirant le 12/20/2027). Le d茅p么t signale 30,000 actions d茅tenues indirectement par un grantor retained annuity trust (GRAT). Toutes les op茅rations ont 茅t茅 d茅clar茅es sur un Form 4 sign茅 par un mandataire.
Christopher E. Kubasik, Vorsitzender und CEO sowie Direktor von L3Harris Technologies (LHX), meldete Transaktionen vom 08/11/2025 in Bezug auf Stammaktien des Unternehmens. Die Einreichung weist einen Verkauf von 40,138 Aktien mit gewichteten durchschnittlichen Verkaufspreisen im Bereich von $267.99 bis $270.63 aus. Der Bericht offenbart au脽erdem eine nicht qualifizierte Aktienoption mit einem Aus眉bungspreis von $149.31, die 40,138 Aktien abdeckt (aus眉bbar ab 06/29/2019, Laufzeit bis 12/20/2027). Die Einreichung vermerkt 30,000 Aktien, die indirekt von einem Grantor Retained Annuity Trust (GRAT) gehalten werden. Alle Transaktionen wurden in einem Form 4 gemeldet, das von einem Bevollm盲chtigten unterzeichnet wurde.
FAQ
What did Christopher E. Kubasik report on the Form 4 for LHX?
How many shares were sold and at what prices in the LHX Form 4?
Does the filing show any indirect holdings for the reporting person?
What are the exercisable and expiration dates for the reported options?
Was the Form 4 signed directly by the reporting person?
